Stay updated on Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.

Latest updates to the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page
- Check2 days agoChange DetectedA new page revision tag indicates the study page was updated from version v3.6.3 to v3.6.4. This appears to be a minor metadata update rather than a substantive change to the study content.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.6.3 was recorded in the page history, replacing v3.6.2. This is a minor version update and does not change the study details or user-visible content.SummaryDifference0.0%

- Check31 days agoChange DetectedThe revision history now displays v3.6.2 as the current page version, replacing the previous v3.6.0. This indicates the page content has been refreshed to a newer version.SummaryDifference0.0%

- Check45 days agoChange DetectedThe study page now notes that recruitment is closed and no longer accepting participants.SummaryDifference0.2%

- Check53 days agoChange DetectedThe recruitment status was updated to Active, not recruiting; enrollment and site counts were revised (276 estimated to 257 actual; 217 locations to 204), and the page version was bumped to v3.5.5.SummaryDifference15%

- Check74 days agoChange DetectedThe study page was updated to Revision: v3.5.4, representing an internal update to the page's revision history. It does not modify any study details, endpoints, or inclusion criteria visible to users.SummaryDifference0.0%

Stay in the know with updates to Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.